| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director
2 companies
Raab Michael is a President &CEO at ARDELYX, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $11.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | ARDX Ardelyx, Inc. | President &CEO | Sell | 6,124 | $0.67 | $4,111.65 | -0.8% | +62.3% | +443.5% | |
| May 2, 2022 | FOLD Amicus Therapeutics, Inc. | Director | Sale+OE | 15,000 | $6.99 | $104,890.50 | -29.0% | +40.1% | +64.8% | |
| Feb 22, 2022 | ARDX Ardelyx, Inc. | President &CEO | Sell | 6,229 | $0.67 | $4,173.43 | -0.8% | -7.6% | +332.8% | |
| Nov 22, 2021 | ARDX Ardelyx, Inc. | President &CEO | Sell | 2,607 | $0.99 | $2,585.88 | -0.4% | -26.8% | +98.6% | |
| Aug 20, 2021 | ARDX Ardelyx, Inc. | President &CEO | Sell | 2,573 | $1.32 | $3,396.36 | -0.8% | -26.3% | -23.9% | |
| May 20, 2021 | ARDX Ardelyx, Inc. | President &CEO | Sell | 2,534 | $7.09 | $17,960.49 | -1.2% | -79.9% | -90.4% | |
| Feb 22, 2021 | ARDX Ardelyx, Inc. | President &CEO | Sell | 2,534 | $6.88 | $17,440.26 | -1.2% | +0.4% | -90.1% | |
| Sep 15, 2020 | ARDX Ardelyx, Inc. | President &CEO | Sell | 106,337 | $5.61 | $596,284.73 | -50.4% | - | - | |
| Jul 2, 2020 | ARDX Ardelyx, Inc. | President &CEO | Sell | 23,128 | $7.01 | $162,129.59 | -48.7% | - | - | |
| Jun 1, 2020 | ARDX Ardelyx, Inc. | President &CEO | Sell | 23,128 | $7.33 | $169,634.63 | -33.3% | - | - |